This AvalonBay Communities Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• JP Morgan analyst Brian Cheng downgraded the rating for Allogene Therapeutics, Inc. (NASDAQ:ALLO) from Overweight to Neutral. Allogene Therapeutics shares closed at $1.08 on Friday. See how other analysts view this stock.
• Piper Sandler analyst Alexander Goldfarb downgraded AvalonBay Communities, Inc. (NYSE:AVB) from Overweight to Neutral and cut the price target from $255 to $200. AvalonBay Communities shares closed at $184.44 on Friday. See how other analysts view this stock.
• Wolfe Research analyst Andy Chen downgraded the rating for Vera Therapeutics, Inc. (NASDAQ:VERA) from Outperform to Peer Perform. Vera Therapeutics shares closed at $20.95 on Friday. See how other analysts view this stock.
• HSBC analyst Kim Fustier downgraded Shell plc (NYSE:SHEL) from Buy to Hold and lowered the price target from $78.9 to $78.3. Shell shares closed at $72.00 on Friday. See how other analysts view this stock.

Considering buying AVB stock? Here’s what analysts think:

Read This Next:

• Wall Street’s Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

Photo via Shutterstock